Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...
SAN ANTONIO — The Dodgers aren’t counting on Shohei Ohtani to pitch at the start of next season and will wait to see how his rehabilitation progresses following shoulder surgery on his non-throwing ...
Basel, 05 November 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology (ASH) An ...